Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1433497)	1/15/2024 1:03:56 PM
From: Maple MAGA	1 Recommendation Recommended By longz Read Replies (1) \| Respond to of 1573213

Pathologist Arne Burkhardt Final Interview – Revealing the Grave Dangers of mRNA Vaccines *“Autopsy is not only a service to the doctors who were responsible for the patient, but it is a public service for our health system.” – Prof. Dr. Arne Burkhardt* Many cases of sudden death and severe disease are being reported since the rollout of the COVID-19 gene-based vaccines. Early on, several doctors and scientists warned that the COVID vaccines would lead to several complications including autoimmune disease, blood clots, strokes, and more. Additionally, The Vaccine Adverse Event Reporting System, or VAERS, data showed a strong correlation between the vaccines and adverse events. But how does one determine in an individual case that the vaccine was the cause of death or the adverse event? It is through pathology. An early pioneer of pathological investigations into vaccine adverse events was Prof. Arne Burkhardt — a senior, highly accomplished pathologist from Germany. Prof. Burkhardt came out of retirement in 2021 to examine the autopsy and biopsy materials of vaccinated patients. The work of Prof. Burkhardt not only provided strong evidence of vaccine causation, it substantiated the professional medical hypotheses of doctors and scientists around the world. Journalist Taylor Hudak interviewed Prof. Burkhardt in his laboratory in Reutlingen, Germany, shortly before his death in May 2023. Prof. Burkhardt explains several of his findings in detail as well as which testing mechanisms he uses. Additionally, he shares his perspectives on the public health industry and academic and medical science as well as what motivates him to do this work.